MFHAS1 Is Associated with Sepsis and Stimulates TLR2/NF-κB Signaling Pathway Following Negative Regulation

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Zhong, Jing ^a,b   Shi, Qi Qing ^c   Zhu, Min Min ^a,b   Shen, Jian ^a,b   Wang, Hui Hui ^a,b   Ma, Duan ^b   Miao, Chang Hong ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPEPTIDE; MFHAS1 PROTEIN, HUMAN; ONCOPROTEIN; PAM(3)CSK(4) PEPTIDE; TOLL LIKE RECEPTOR 2;

AGED; AGONISTS; ANIMAL; CELL CULTURE; CELL LINE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEK293 CELL LINE; HUMAN; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; RAT; SEPSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGED; ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE; CELLS, CULTURED; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEK293 CELLS; HUMANS; INTERLEUKIN-6; LIPOPEPTIDES; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; ONCOGENE PROTEINS; RATS; SEPSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84957990919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143662     Document Type: Article

References (41)

1. Dihanich S. MASL1: a neglected ROCO protein. Biochemical Society transactions. 2012; 40(5):1090-4 PMID: 22988871
2. Dihanich S, Civiero L, Manzoni C, Mamais A, Bandopadhyay R, Greggio E, et al. GTP binding controls complex formation by the human ROCO protein MASL1. The FEBS journal. 2014; 281(1):261-74. doi: 10.1111/febs.12593 PMID: 24286120
3. Sakabe T, Shinomiya T, Mori T, Ariyama Y, Fukuda Y, Fujiwara T, et al. Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization. Cancer research. 1999; 59(3):511-5. PMID: 9973190
4. Weng WH, Wejde J, Ahlen J, Pang ST, Lui WO, Larsson C. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. Cancer genetics and cytogenetics. 2004; 150(1):27-32. PMID: 15041220
5. Kumkhaek C, Aerbajinai W, Liu W, Zhu J, Uchida N, Kurlander R, et al. MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway. Blood. 2013; 121(16):3216-27. doi: 10.1182/blood-2011-10-385252 PMID: 23327923
6. Ng AC, Eisenberg JM, Heath RJ, Huett A, Robinson CM, Nau GJ, et al. Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunity. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108 Suppl 1:4631-8. doi: 10.1073/pnas.1000093107 PMID: 20616063
7. Zheng G, Lyu J, Huang J, Xiang D, Xie M, Zeng Q. Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2015; 20(2):185-95.
8. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007; 449(7164):819-26. PMID: 17943118
9. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-Analysis. Critical care medicine. 2014; 42 (3):625-31. doi: 10.1097/CCM.0000000000000026 PMID: 24201173
10. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. American journal of respiratory and critical care medicine. 2009; 180(9):861-6. doi: 10.1164/rccm.200812-1912OC PMID: 19696442
11. Schorr CA, Dellinger RP. The Surviving Sepsis Campaign: past, present and future. Trends in molecular medicine. 2014; 20(4):192-4. doi: 10.1016/j.molmed.2014.02.001 PMID: 24698888
12. Yao YM, Luan YY, Zhang QH, Sheng ZY. Pathophysiological aspects of sepsis: an overview. Methods in molecular biology (Clifton, NJ). 2015; 1237:5-15.
13. Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence. 2014; 5(1):20-6. doi: 10.4161/viru.27135 PMID: 24280933
14. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell host & microbe. 2008; 3(6):352-63.
15. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124(4):783-801. PMID: 16497588
16. Sellge G, Kufer TA. PRR-signaling pathways: Learning from microbial tactics. Seminars in immunology. 2015; 27(2):75-84. doi: 10.1016/j.smim.2015.03.009 PMID: 25911384
17. Shibata T, Nakashima F, Honda K, Lu YJ, Kondo T, Ushida Y, et al. Toll-like receptors as a target of food-derived anti-inflammatory compounds. The Journal of biological chemistry. 2014; 289(47):32757-72 doi: 10.1074/jbc.M114.585901 PMID: 25294874
18. Hoang M, Potter JA, Gysler SM, Han CS, Guller S, Norwitz ER, et al. Human fetal membranes generate distinct cytokine profiles in response to bacterial Toll-like receptor and nod-like receptor agonists. Biology of reproduction. 2014; 90(2):39. doi: 10.1095/biolreprod.113.115428 PMID: 24429216
19. Beutler BA. TLRs and innate immunity. Blood. 2009; 113(7):1399-407. doi: 10.1182/blood-2008-07-019307 PMID: 18757776
20. Foley NM, Wang J, Redmond HP, Wang JH. Current knowledge and future directions of TLR and NOD signaling in sepsis. Military Medical Research. 2015; 2:1. doi: 10.1186/s40779-014-0029-7 PMID: 25722880
21. Brightbill HD, Modlin RL. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology. 2000; 101(1):1-10. PMID: 11012747
22. Bosmann M, Ward PA. The inflammatory response in sepsis. Trends in immunology. 2013; 34(3):129- doi: 10.1016/j.it.2012.09.004 PMID: 23036432
23. Li Y, Xiong W, Yang J, Zhong J, Zhang L, Zheng J, et al. Attenuation of Inflammation by Emodin in Lipopolysaccharide-induced Acute Kidney Injury via Inhibition of Toll-like Receptor 2 Signal Pathway. Iranian journal of kidney diseases. 2015; 9(3):202-8. PMID: 25957424
24. Peng Y, Zhang X, Wang Y, Li S, Wang J, Liu L. Overexpression of toll-like receptor 2 in glomerular endothelial cells and podocytes in septic acute kidney injury mouse model. Renal failure. 2015; 37 (4):694-8. doi: 10.3109/0886022X.2015.1011499 PMID: 25715637
25. Zhong J, Colicino E, Lin X, Mehta A, Kloog I, Zanobetti A, et al. Cardiac autonomic dysfunction: particulate air pollution effects are modulated by epigenetic immunoregulation of Toll-like receptor 2 and dietary flavonoid intake. Journal of the American Heart Association. 2015; 4(1):e001423. doi: 10.1161/JAHA.114.001423 PMID: 25628407
26. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000; 406(6797):782-7. PMID: 10963608
27. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. Journal of immunology (Baltimore, Md: 1950). 2000; 165(10):5392-6.
28. Gong Y, Zou L, Feng Y, Li D, Cai J, Chen D, et al. Importance of Toll-like receptor 2 in mitochondrial dysfunction during polymicrobial sepsis. Anesthesiology. 2014; 121(6):1236-47. doi: 10.1097/ALN. 0000000000000470 PMID: 25272245
29. Takeda K, Akira S. TLR signaling pathways. Seminars in immunology. 2004; 16(1):3-9. PMID: 14751757
30. Dupuy AM, Philippart F, Pean Y, Lasocki S, Charles PE, Chalumeau M, et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review: I-currently available biomarkers for clinical use in acute infections. Annals of intensive care. 2013; 3(1):22. doi: 10.1186/2110-5820-3-22 PMID: 23837559
31. Kojic D, Siegler BH, Uhle F, Lichtenstern C, Nawroth PP, Weigand MA, et al. Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? World journal of experimental medicine. 2015; 5(2):50-63. doi: 10.5493/wjem.v5.i2.50 PMID: 25992320
32. Dumache R, Rogobete AF, Bedreag OH, Sarandan M, Cradigati AC, Papurica M, et al. Use of miRNAs as Biomarkers in Sepsis. Analytical cellular pathology (Amsterdam). 2015; 2015:186716.
33. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nature medicine. 2003; 9(5):517-24. PMID: 12724763
34. Sharawy N, Lehmann C. New directions for sepsis and septic shock research. The Journal of surgical research. 2015; 194(2):520-7. doi: 10.1016/j.jss.2014.12.014 PMID: 25596653
35. Ma J, Chen C, Barth AS, Cheadle C, Guan X. Lysosome and Cytoskeleton Pathways Are Robustly Enriched in the Blood of Septic Patients: A Meta-Analysis of Transcriptomic Data. 2015;2015:984825.
36. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive care medicine. 2013; 39(2):165-228. doi: 10.1007/s00134-012-2769-8 PMID: 23361625
37. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Critical care medicine. 1996; 24(7):1125-8. PMID: 8674323
38. Fijen JW, Kobold AC, de Boer P, Jones CR, van der Werf TS, Tervaert JW, et al. Leukocyte activation and cytokine production during experimental human endotoxemia. European journal of internal medicine. 2000; 11(2):89-95. PMID: 10745152
39. Marik PE, Flemmer M. The immune response to surgery and trauma: Implications for treatment. The journal of trauma and acute care surgery. 2012; 73(4):801-8. doi: 10.1097/TA.0b013e318265cf87 PMID: 22976420
40. Gomez HG, Gonzalez SM, Londono JM, Hoyos NA, Nino CD, Leon AL, et al. Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study. Critical care medicine. 2014; 42(4):771-80. doi: 10.1097/CCM.0000000000000100 PMID: 24365860
41. Rosenthal M, Gabrielli A, Moore F. The evolution of nutritional support in long term ICU patients: from multisystem organ failure to persistent inflammation immunosuppression catabolism syndrome. Minerva anestesiologica. 2015.